All Publications
Journal Article

Comparative Multi-Country Evaluation of Colorimetric Rt-Lamp for Sars-Cov-2 Detection from Nasopharyngeal Swabs or from Crude Saliva in Africa

Molalegne Birew, Šušnjar, Urša, Bitew, Molalegne, Ayele, Samuele, Uršič, Tina, P... 2024 Health Biotechnology
Background : Reverse-transcriptase loop-mediated isothermal amplification (RT-LAMP) is a rapid, robust, simple, and cost-effective one-step amplification assay for the identification of SARS-CoV-2 RNA in nasopharyngeal (NP) swabs. Herein, we demonstrate the expansion of RT-LAMP in Africa and its operational performance directly from saliva as a pragmatic approach for outbreak surveillance and response in resource-limited settings in Africa.Methods: A multi-country diagnostic trial of RT-LAMP was conducted between September 2021 and June 2022 on 2774 NP swabs in seven countries (Angola, Burkina-Faso, Ivory Coast, Ethiopia, Senegal, Sudan, and Zimbabwe). In parallel, 577 saliva samples were tested with RT-LAMP (without RNA extraction) in four countries (Cameroon, Ethiopia, Kenya, and Nigeria). In both contexts, real-time quantitative polymerase chain reaction (RT-qPCR) using RNA extracted from NP swabs was used as gold-standard benchmarking assay to evaluate performance of RT-LAMP.Findings: The overall sensitivity and specificity of RT-LAMP across countries were 89% (95%CI: 87-90%) and 95% (95%CI: 93-96%), respectively, with positive predictive value (PPV) 95% (95%CI: 94-96%) and negative predictive value (NPV) 88% (95%CI: 86-89%). Similarly, RT-LAMP applied to saliva without RNA extraction showed 80% (95%CI: 75-84%) sensitivity, 99% (95%CI: 96-100%) specificity, 99% (95% CI: 97-100) PPV and 77% (95% CI: 77-82) NPV.Interpretation: Colorimetric RT-LAMP is a reliable assay for SARS-CoV-2 detection in both extracted RNA and crude saliva samples. Its good performance on crude saliva samples (without RNA extraction) underscores scalability for efficient outbreak surveillance in resource-limited settings.
The Lancet
47
Quick Details
Year2024
TypeJournal Article
DirectorateHealth Biotechnology
Share